ArticleActa physiologica (Oxford, England)2026
P2X7-NEK7-NLRP3 Axis Drives Cardiac Inflammation and Fibrosis in Isoproterenol-Induced Cardiac Remodeling in Mice.
Article in Acta physiologica (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
aimCardiac remodeling (CR) is a critical risk factor for the development and progression of cardiovascular diseases. CR is accompanied by activation of the innate immune response, with NLRP3 inflammasome emerging as a key player in morphological and functional changes. However, the mechanisms underlying NLRP3 inflammasome assembly and activation in the heart upon beta-adrenergic overactivation remain poorly understood. This study aims to investigate the temporal profile of NLRP3 inflammasome activation and its upstream signaling P2X7-NEK7 in isoproterenol (ISO)-induced CR.
methodsWild-type (WT), NLRP3 knockout (NLRP3-KO), and P2X7-KO male mice were treated with ISO (60 mg/kg) for 1 h, 12 h, 24 h, or 14 days. Cardiac function was assessed by echocardiography and plethysmography. Cardiac hypertrophy and fibrosis were evaluated by histology. Fibrosis markers and cytokines gene expression were analyzed by quantitative PCR. Protein expression was evaluated by Western Blotting. Inflammasome assembly was confirmed by ASC speck immunofluorescence.
resultsWT mice showed a rapid activation of NLRP3 inflammasome in the heart up to 12 h from ISO administration, evidenced by increased NLRP3, ASC speck, Caspase-1, and IL-1β. ISO treatment for 12 h also increased P2X7 and NEK7. NLRP3-KO mice were protected from ISO-induced fibrosis and impairment of LV relaxation as well as the Caspase-1 activation and cytokines production. NEK7, NLRP3 activation, and fibrosis were prevented in P2X7-KO. NLRP3 deletion did not affect ISO-induced cardiac hypertrophy.
conclusionThese findings suggest that the NLRP3 inflammasome is activated by the P2X7-NEK7 pathway in the early stage of beta-adrenergic insult, driving ISO-induced cardiac fibrosis and inflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.